{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:18:25Z","timestamp":1757614705338,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2023,11,21]]},"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1136\/ejhpharm-2023-003853","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T13:20:25Z","timestamp":1701436825000},"page":"161-165","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome"],"prefix":"10.1136","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9006-380X","authenticated-orcid":false,"given":"Gerda","family":"Ratzinger-Stoeger","sequence":"first","affiliation":[{"name":"Pharmacy Department, AKH Wien, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Anzengruber","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Skoll","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana-Alexandra","family":"Ertl","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Wien, Austria"},{"name":"Vienna Bone and Growth Center, Medical University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Wien, Austria"},{"name":"Vienna Bone and Growth Center, Medical University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Gabor","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Vienna, Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2025090502094528000_32.2.161.1","doi-asserted-by":"crossref","unstructured":"de Mingo C , Brugada M , Le\u00f3n S , et al . Metyrapone as treatment in the neonatal McCune-Albright syndrome. J Pediatr Endocrinol Metab 2020. doi:10.1515\/jpem-2020-0036","DOI":"10.1515\/jpem-2020-0036"},{"key":"2025090502094528000_32.2.161.2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1014"},{"key":"2025090502094528000_32.2.161.3","first-page":"233","article-title":"Rectal metyrapone for treatment of hypercortisolism in an infant with McCune-Albright syndrome","volume":"22","author":"Verbeeten","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2025090502094528000_32.2.161.4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40267-021-00853-y","article-title":"Metyrapone in Cushing\u2019s syndrome: a profile of its use","volume":"37","author":"Al-Salama","year":"2021","journal-title":"Drugs Ther Perspect"},{"key":"2025090502094528000_32.2.161.5","doi-asserted-by":"crossref","unstructured":"Ertl D-A , Ratzinger-Stoeger G , Raimann A , et al . Successful use of Metyrapone Suppositories in an infant with neonatal Cushing and Mccune Albright syndrome - a case report. Horm Res Paediatr November 24, 2023. doi:10.1159\/000535266","DOI":"10.1159\/000535266"},{"key":"2025090502094528000_32.2.161.6","unstructured":"HRA Pharma Rare Diseases . Metycor Fachinformation; 2022."},{"key":"2025090502094528000_32.2.161.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.04.042"},{"key":"2025090502094528000_32.2.161.8","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/acs.molpharmaceut.5b00961","article-title":"Design of controlled release PLGA microspheres for hydrophobic fenretinide","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol Pharm"},{"key":"2025090502094528000_32.2.161.9","doi-asserted-by":"crossref","unstructured":"Haas S , Woerdenbag H , Sznitowska M . Rectal and vaginal. Practical Pharmaceutics 2015:190\u2013227. doi:10.1007\/978-3-319-15814-3","DOI":"10.1007\/978-3-319-15814-3_11"},{"key":"2025090502094528000_32.2.161.10","doi-asserted-by":"crossref","unstructured":"Touw D , Vigneron J . Stability. Practical Pharmaceutics 2015:436\u201359. doi:10.1007\/978-3-319-15814-3","DOI":"10.1007\/978-3-319-15814-3_22"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-003853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:13:14Z","timestamp":1757063594000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-003853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,21]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/ejhpharm-2023-003853"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-003853","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}